<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="222313">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00189111</url>
  </required_header>
  <id_info>
    <org_study_id>METC.2004.100-GROUND</org_study_id>
    <nct_id>NCT00189111</nct_id>
  </id_info>
  <brief_title>Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study</brief_title>
  <official_title>Non-Invasive Cardiac Screening in High Risk Patients -The GROUND Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UMC Utrecht</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UMC Utrecht</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out if subjecting cardiac high risk patients to non
      invasive cardiac imaging, followed by treatment will improve survival and quality of life
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral arterial disease (PAD) is a common disease associated with a considerably
      increased risk of future events and with a high prevalence of coronary artery disease (CAD).
      Improvement of the prognosis of this patient group is needed. Screening for CAD has become
      an option with recent developments in CT-angiography and MR stress testing. It is unknown if
      high-risk patient groups benefit from screening through non-invasive cardiac imaging.
      Therefore we propose to study whether a cardiac imaging algorithm, using non-invasive
      imaging techniques followed by evidence-based treatment will reduce the risk of
      cardiovascular disease in cardiac asymptomatic PAD patients.

      The GROUND study is designed as a prospective, multi-center, randomized clinical trial.
      Patients with peripheral arterial disease, but yet without a history of symptomatic cardiac
      disease will be asked to participate. All patients receive a proper therapeutic advice
      before randomization. Half of the recruited patients will enter the 'control group' and only
      receive CT calcium scoring. The other half of the recruited patients (index group) will
      undergo the non invasive cardiac imaging algorithm followed by evidence-based treatment.
      First patients undergo CT calcium scoring and CT angiography. Patients with a left main (or
      equivalent) coronary artery stenosis on CT angiography will be referred to a cardiologist
      without further imaging. All other patients in this group will undergo Dobutamine Stress
      Magnetic Resonance (DSMR) testing. Patients with a DSMR positive for ischemia will also be
      referred to a cardiologist. Most referred patients will very likely undergo conventional
      coronary artery angiography and cardiac interventions (CABG or PCI) if indicated. All
      participants of the trial will enter a 5 year follow up period for the occurrence of future
      cardiovascular events. Interim analysis will take place and based on power calculations
      about 1200 patients are needed to reach significance.

      Implications The GROUND study will provide new insight into the question whether
      non-invasive cardiac imaging reduces the risk of cardiovascular events in patients with
      peripheral arterial disease, but yet without symptoms of coronary artery disease as an
      example of a high risk patient group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2005</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cardiovascular mortality</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiovascular morbidity</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fatal and non-fatal myocardial infarction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fatal and non-fatal stroke</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular interventions</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amputation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aortic rupture</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>End stage renal failure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Extra cranial hemorrhage</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of CABG or PTCA</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac Imaging + Treatment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with peripheral arterial disease, diagnosed by the vascular surgeon

          -  Patients must provide consent in writing after proper education and discussion with
             the treating physician and/or research physician

          -  Patients must be aged 50 years or over

        Exclusion Criteria:

          -  History of symptomatic cardiac disease

          -  Cardiac rhythm other than sinus

          -  Unable to sustain a breath-hold for 25 seconds

          -  Asthma (contraindication beta-blockers)

          -  Contra-indications to MRI examination.

          -  Contra-indications to iodine contrast.

          -  Severe arterial hypertension (&gt;220/120 mmHg)

          -  Significant aortic stenosis

          -  Unable to remain in supine position for at least 60 minutes

          -  Morbidly obese (BMI &gt; 40)

          -  Renal insufficiency (creatinine &gt;140mmol/l)

          -  Severe physical deterioration due to concomitant illness

          -  Language barrier

          -  Acute coronary syndrome

          -  Contra-indications to dobutamine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>W. Mali, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UMC Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>M. Oudkerk, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>M.L. Bots, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Julius Center, University Medical Center Utrecht</affiliation>
  </overall_official>
  <overall_official>
    <last_name>F. Zijlstra, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Groningen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>W. Mali, PhD</last_name>
    <phone>+31302506684</phone>
    <email>w.mali@azu.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>A.M. de Vos, MD</last_name>
    <phone>+31302506687</phone>
    <email>a.m.devos@azu.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Meander Medical Center</name>
      <address>
        <city>Amersfoort</city>
        <state>Utrecht</state>
        <zip>3800 BM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A. Mosterd, PhD</last_name>
      <phone>+31334222469</phone>
      <email>a.mosterd@meandermc.nl</email>
    </contact>
    <contact_backup>
      <last_name>R. Buiskool, PhD</last_name>
      <phone>+31334214526</phone>
      <email>R.Buiskool@meandermc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>A. Mosterd, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>R. Buiskool, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>B Heggelman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A. Mackaay</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <state>Utrecht</state>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>B. Rensing, PhD</last_name>
      <phone>+31306099111</phone>
      <email>b.rensing@antonius.net</email>
    </contact>
    <investigator>
      <last_name>B. Rensing, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>H. Van Es, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H. Van Der Pavoordt, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bronovo Hospital</name>
      <address>
        <city>The Hague</city>
        <state>Zuid-Holland</state>
        <zip>2597 AX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. Van Dijkman, PhD</last_name>
      <phone>+31703124365</phone>
      <email>pvdijkman@bronovo.nl</email>
    </contact>
    <investigator>
      <last_name>P. Van Dijkman, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Th. Kuijpers, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H.J. Smeets, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9700 RB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Oudkerk, PhD</last_name>
      <phone>+31503614260</phone>
      <email>m.oudkerk@umcg.nl</email>
    </contact>
    <contact_backup>
      <last_name>E. Noach, PhD</last_name>
      <phone>+31503619976</phone>
      <email>e.j.k.noach@rad.umcg.nl</email>
    </contact_backup>
    <investigator>
      <last_name>M. Oudkerk, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>F. Zijlstra, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>E. Noach, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>H.J. Van der Zaag, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Mali, PhD</last_name>
      <phone>+31302506684</phone>
      <email>w.mali@azu.nl</email>
    </contact>
    <contact_backup>
      <last_name>A.M. De Vos, MD</last_name>
      <phone>+31302506687</phone>
      <email>a.m.devos@azu.nl</email>
    </contact_backup>
    <investigator>
      <last_name>W. Mali, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>W. Prokop, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>F. Moll, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A. Rutten, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>A.M. De Vos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>P.A. Doevendans, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>M. Cramer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>M.L. Bots, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <lastchanged_date>November 13, 2008</lastchanged_date>
  <firstreceived_date>September 12, 2005</firstreceived_date>
  <keyword>peripheral arterial disease</keyword>
  <keyword>computed tomography</keyword>
  <keyword>cardiac asymptomatic</keyword>
  <keyword>dobutamine magnetic resonance imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
